HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

salicylihalamide A

structure in first source

Also Known As:

salicylihalamide B; salicylihalamide-A

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Bridged-Ring Heterocyclic Compounds
  - Heterocyclic Bridged Bicyclo Compounds
    - salicylihalamide A: 2

Experts

1.	Gorelick, Fred: 1 article (11/2009)
2.	Kolodecik, Thomas: 1 article (11/2009)
3.	Thrower, Edwin: 1 article (11/2009)
4.	Erickson, Karen L: 1 article (05/2008)
5.	Tang, Shaoshan: 1 article (05/2008)

Related Diseases

1.	Pancreatitis 11/19/2009 - "These studies confirm a role for the vATPase in zymogen activation and demonstrate that the novel and specific inhibitors lobatomide-B and salicylihalamide-A reduce early pancreatitis responses." 11/19/2009 - "In the current study we examine the role of the vATPase in pancreatitis using the newly developed novel vATPase inhibitors lobatomide-B and salicylihalamide-A as well as a genetic approach using siRNA. "
2.	Neoplasms (Cancer) 05/01/2008 - "Its cytotoxicity profile in the NCI 60-cell-line human tumor assay differed significantly from that of salicylihalamide A in both level and specificity."

Related Drugs and Biologics

1.	Small Interfering RNA (siRNA)
2.	Enzyme Precursors (Zymogens)